Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos March 27, 2017 Genentech's Top Cancer Prospect Flunks Phase III Test May 9, 2017 Is There A Silver Lining For Fitbit? February 14, 2017
Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos March 27, 2017